Cluster Headache Market Analysis By Drug Class(Fast-acting Drugs, Long-term Drugs, Short-term Drugs), By Type(Episodic, Chronic), By Route of Administration(Oral, Topical, Intravenous), By Distribution Channel(Hospital, Pharmacies, Retail Pharmacies, Online Pharmacies) & Forecast
- PUBLISHED ON
- 24/03/2023
- NO OF PAGES
- 218
- CATEGORY
- Healthcare & Life Sciences
The rising global elderly population is one of the major factors for the market growth during the forecasted period. As per the World Population Prospects 2019 (United Nations, 2019), by 2050, one in six people will be above the age of 65 worldwide, which will be up from one in 11 people in 2019.
The growing incidences of cluster headache syndrome. As per the latest epidemiological studies, one in 500 people experience cluster headaches. The global cluster headache market is predicted to increase owing to upsurge in number of cluster headache patients with a favourable family history. For instance, as per the study article published by Bio Med Central (BMC) in April 2020, a systematic review and meta-analysis was directed in agreement with the criteria for favoured reporting items for systematic reviews and meta-analysis protocols. With a total I2%-73%, it was discovered that anticipated prevalence of CH patients with a family history was approximately 6.27%.
Pharmaceutical and biotech companies together with administrations across the world are functioning to address the COVID-19 eruption, from assisting the development of vaccines to scheduling for medicine supply chain problems. Presently, about 115 vaccine contenders and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have observed a dramatic growth in demand for the managing COVID-19. Such high request for these drugs has offered huge prospects for manufacturers of COVID-19 controlling drugs, as many established nations are facing deficiency of these drugs. Thus, the pharmaceutical and biotechnology industries are projected to witness a substantial growth in the future, due to the need for vaccine and treatment drugs for COVID-19. This, in turn, is anticipated to have a substantial impact on the cluster headache market.
Drug Type Insights
Among drug type, fast-acting drugs holds a leading position in the global cluster headache market. Anti-inflammatory medications known as corticosteroids, such as prednisone, are fast-acting protective drugs that can be operative for numerous people with cluster headaches.
Type Insights
Based on the type, the cluster headache market is categorized into episodic and chronic. The chronic segment holds the maximum market share during the forecasted period. The chronic type of cluster headache disturbs most patients. The episodic form of the cluster headache may grow over time into the chronic form, or it may be chronic from the start, which boosts the segment’s growth.
Region Insights
In 2021, North America rules the global cluster headache market, owing to innovative healthcare structure alongside the arrival of unconventional technologies to detect the syndrome and the growing prevalence of migraines.
However, Asia Pacific is projected to have the highest growth rate for the forecasted period. This is owing to augmented spending on health infrastructure growth, coupled with an increasing elderly population base.
Key Companies Insights
The market for cluster headache is moderately competitive. With the rising applications of Cluster headache, new players are considering to enter the market. The companies are also involved in activities like joint ventures, acquisitions, partnerships, mergers, and collaborations. These activities aid in growing the effect of the players in the cluster headache market, ultimately boosting the market growth.
• Zosano Pharma
• Eli Lilly and Company
• Lundbeck Seattle BioPharmaceutical
• Winston Laboratories
• GlaxoSmithKline plc.
• ElectroCore Medical LLC
• Autonomic Technologies, Inc.
• AstraZeneca plc.
• Allergan plc.
• Bayer AG
• F. Hoffmann-La Roche Ltd
• Novartis AG
• Sun Pharmaceutical Industries Ltd
• Teva Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Company Limited
• Sanofi
• AbbVie Inc.
• Other players
Some of the Recent Developments:
• In 2019, Eli Lilly and Company received the approval of Food and Drug Administration on Galcanezumab (Brand Name: Emgality), an antibody used for migraine and cluster headache.
• In 2017, ElectroCore launched gammaCore, a non-invasive vagus nerve stimulator, to treat the acute pain related to episodic cluster headache in adults.
Segments
By Drug Class
• Fast-acting Drugs
• Long-term Drugs
• Short-term Drugs
By Type
• Episodic
• Chronic
By Route of Administration
• Oral
• Topical
• Intravenous
• Others
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
• Latin America
o Brazil
o Argentina
o Colombia
• MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
}})
Select a license type that suits your business needs
US $4250
Only Four Thousand Two Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $5250
Only Five Thousand Two Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $6250
Only Six Thousand Two Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI